Striatal dopamine release regulation by the cholinergic properties of the smokeless tobacco, gutkha

ACS Chemical Neuroscience
Brian O'NeillMargaret E Rice

Abstract

Tobacco products influence striatal dopamine (DA) release primarily through the actions of nicotine, an agonist of nicotinic acetylcholine receptors (nAChR). Gutkha is a smokeless tobacco product that contains not only nicotine, but also includes the habit-forming areca nut and other plant-based constituents that contribute muscarinic acetylcholine receptor (mAChR) agonists and other cholinergic agents. Thus, the net influence of the cholinergic agents in gutkha on striatal DA release is difficult to predict. This study investigated the influence of gutkha extract on evoked DA release in mouse striatal slices using fast-scan cyclic voltammetry. The potency of a given concentration of nicotine in the gutkha extract was found to be significantly lower than that of a comparable concentration of nicotine alone. Atropine, a mAChR antagonist, increased the potency of gutkha-associated nicotine; however, other experiments suggested that this was mediated in part by direct effects of atropine at nAChRs. Overall, these results suggest that the unique constituents of gutkha work together to oppose the influence of gutkha-associated nicotine on evoked striatal DA release.

References

Jul 11, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·L ReE Mosca
Mar 29, 2001·Biochemical Pharmacology·T J ParkK T Kim
Jun 1, 2001·Journal of Biomedical Science·N S Chu
Mar 20, 2002·Addiction Biology·A Winstock
Dec 11, 2002·Biochemical Pharmacology·Tae-Ju ParkKyong-Tai Kim
May 18, 2004·Nature Neuroscience·Hui Zhang, David Sulzer
May 18, 2004·Nature Neuroscience·Margaret E Rice, Stephanie J Cragg
Mar 1, 2005·European Journal of Pharmacology·Chantal J G M SmuldersHenk P M Vijverberg
May 26, 2005·Brain Research. Brain Research Reviews·Hai Wang, Xiulan Sun
Sep 10, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Adyary FallareroPia M Vuorela
Jun 16, 2009·Biochemical Pharmacology·Phil D Livingstone, Susan Wonnacott
Jul 28, 2009·Current Drug Abuse Reviews·Matthew J WanatPaul E M Phillips
Mar 6, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sarah ThrelfellStephanie J Cragg
Aug 20, 2011·Substance Abuse Treatment, Prevention, and Policy·Saira S MirzaMoin I Arain
Nov 18, 2011·Indian Journal of Public Health·Prakash C GuptaPoonam K Singh
Jan 20, 2012·Bioorganic & Medicinal Chemistry·Preet AnandNirmal Singh
Mar 1, 2012·Neurochemistry International·Ravichandran SrividhyaPeriandavan Kalaiselvi
Jun 5, 2012·Journal of Agricultural and Food Chemistry·George D GeromichalosZacharias Sinakos
Aug 3, 2012·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Daniel WillisJudith Zelikoff
Jan 9, 2013·Methods in Molecular Biology·Jyoti C Patel, Margaret E Rice
Apr 13, 2013·Journal of Immigrant and Minority Health·Smita C BanerjeeFrancesca Gany
Jan 15, 2014·International Journal of Environmental Research and Public Health·Daniel N WillisJudith T Zelikoff
Jul 6, 2014·Pharmacognosy Magazine·Manoj K DalaiPulok K Mukherjee

❮ Previous
Next ❯

Citations

Sep 2, 2017·Diagnostic Cytopathology·Adile Ferda DagliSuleyman Aydin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.